Intensive Intravenous Amphotericin B for Prophylaxis of Systemic Fungal Infections

Publisher： Karger

E-ISSN： 1421-9794|46|4|293-302

ISSN： 0009-3157

Source： Chemotherapy, Vol.46, Iss.4, 2000-06, pp. : 293-302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Amphotericin B, an Anti-Fungal Medication, Directly Increases the Cytotoxicity of NK Cells

By Kim Nayoung   Choi Ji-Wan   Park Hye-Ran   Kim Inki   Kim Hun Sik  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-06 ,pp. : 1262-1262

MDPI

Access to resources Recommend Favorite

Systemic Fungal Infections in Patients with Hematologic Malignancies: Indications and Limitations of the Antifungal Armamentarium

By  

Chemotherapy, Vol. 45, Iss. 5, 1999-08 ,pp. : 315-324

Karger

Access to resources Recommend Favorite

Clinical Efficacy of Amphotericin B Colloidal Dispersion against Infections Caused by Candida spp

By  

Chemotherapy, Vol. 45, Iss. 1, 1999-07 ,pp. : 27-33

Karger

Access to resources Recommend Favorite

Clinical Efficacy of Amphotericin B Colloidal Dispersion against Infections Caused by Aspergillus spp

By  

Chemotherapy, Vol. 45, Iss. 1, 1999-07 ,pp. : 34-38

Karger

Access to resources Recommend Favorite

Amphotericin B Colloidal Dispersion

By  

Chemotherapy, Vol. 45, Iss. 1, 1999-07 ,pp. : 15-26

Karger

Access to resources Recommend Favorite